Multidisciplinary Study of Novel NMDA Modulation for Neurodegenerative Disorder
Status:
Recruiting
Trial end date:
2022-07-01
Target enrollment:
Participant gender:
Summary
Alzheimer's disease (AD) and Parkinson's disease (PD) are currently the leading
neurodegenerative disorders. Considering the fact that aged population is rapidly growing, it
has become a critical issue to find more effective medications for these two disorders. The
aim of this project is to examine the effectiveness and safety of DAAOI-P treatment for PD
with dementia.